Morgan Stanley Conformis Inc Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.36 $0 - $1	-3 Reduced 0.01%	45,192 $9,000
Q2 2022 Oct 27, 2022	SELL	$0.28 - $0.65 $1,428 - $3,315	-5,100 Reduced 10.14%	45,195 $16,000
Q2 2022 Aug 15, 2022	SELL	$0.28 - $0.65 $1,428 - $3,315	-5,100 Reduced 10.14%	45,195 $16,000
Q1 2022 Oct 27, 2022	BUY	$0.56 - $0.83 $2,856 - $4,233	5,100 Added 11.28%	50,295 $31,000
Q1 2022 May 13, 2022	BUY	$0.56 - $0.83 $2,155 - $3,194	3,849 Added 8.29%	50,295 $31,000
Q4 2021 Feb 14, 2022	BUY	$0.67 - $1.32 $10,790 - $21,258	16,105 Added 53.08%	46,446 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.02 - $1.83 $30,947 - $55,524	30,341 New	30,341 $40,000

5.79K

Ticker CFMS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 187,856,992
Description
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.